Biogen revenue and financials

BIIB · NASDAQ · USD

$223.59Change from previous close: +1.69%Absolute change: +$3.71

Close · October 5, 2026

In the fiscal year ended December 2025, Biogen reported revenue of $9.89B (+2.22% year over year). Net income was $1.29B, a net margin of 13.1%.

Annual revenue · 2025: $9.89B
  1. $11.45B2016
  2. $12.27B2017
  3. $13.45B2018
  4. $14.38B2019
  5. $13.44B2020
  6. $10.98B2021
  7. $10.17B2022
  8. $9.84B2023
  9. $9.68B2024
  10. $9.89B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+2.22%
2025 vs 2024
Net income growth
−20.79%
2025 vs 2024
Net margin
13.1%
2024: 16.9%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item2025202420232022202120202019201820172016
Total assets29,44028,04926,84524,55423,87724,61927,23425,28923,65322,877
Current assets8,9747,4576,8599,7917,8576,8878,3827,6417,8738,732
Cash and equivalents3,0092,3751,0503,4192,2611,3312,9141,2251,5742,327
Short-term investments8070.00.01,4741,541—————
Receivables1,8671,8692,5302,9351,962—————
Inventory2,1682,4612,5271,3441,352—————
Net property, plant and equipment3,3213,5383,7303,7033,792—————
Goodwill6,4916,4796,2195,7495,7615,7625,7585,7064,6333,669
Other intangible assets9,1799,6918,3631,8502,221—————
Long-term investments9554246261,7762,826—————
Current liabilities3,3495,5293,4343,2734,2983,7424,8643,2953,3683,420
Accounts payable432424403492589—————
Long-term debt6,2876,2966,9386,2816,2747,4264,4595,9375,9356,513
Total debt6,5776,6307,3386,614——————
Total liabilities11,18311,33312,04511,16612,91813,93313,89512,25711,05510,748
Total equity (incl. minority)18,25716,71614,79913,38810,960—————
Retained earnings20,55319,26017,62816,46713,912—————
Minority interest——0.0-9.563.5—————